The effect of inhaled heparin on airway responsiveness to metacholine in asthmatic children;Wplyw wziewnej heparyny na pometacholinowy skurcz oskrzeli u dzieci z astma̧ oskrzelowa̧

Polskie Archiwum Medycyny Wewnetrznej

Volumn 106, Issue 1, 2001, Pages 567-572

  Stelmach, Iwona ^a   Jerzyńska, Joanna ^a   Bobrowska, Monika ^a   Brzozowska, Agnieszka ^a   Majak, Pawel ^a   Kuna, Piotr ^b  

^a Samodzielny Oddzia K   (Poland)

^b Klinika Pneumonologii i A

Author keywords

Bronchial hyperreactivity; Heparin; Metacholine

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HEPARIN; METHACHOLINE; MUSCARINIC RECEPTOR; PLACEBO; ANTIINFLAMMATORY AGENT; BRONCHOCONSTRICTING AGENT; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; HUMAN; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING; SCHOOL CHILD; ASTHMA; CHILD; FEMALE; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEPARIN; HUMANS; MALE; METHACHOLINE CHLORIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035412215     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Highlights of the Expert Panel Report 2: Guidelines for the diagnosis and management of asthma (NIH Publication No. 97-4051 A, May 1997).
2. Ahmed T. i wsp.: Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J. Appl. Physiol., 1993, 74(4), 1492.
3. Alendouro P. i wsp.: Heparin modulates the immediate response to allergen? Allergy, 1995, 50, S 24.
4. Cohen S. i wsp.: Inhibition of T lymphocyte by heparin prevents T cell migration. J. Immunol., 1967, 98, 351.
5. Fredens K., Dahl R. Venge P.: In vitro studies of the interaction between heparin and eosinophil cationic protein. Allergy, 1991, 46, 27.
6. Ahmed T. i wsp.: Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation? J. Appl. Physiol., 1994, 76(2), 893.
7. Baram D. i wsp.: Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clin. Exp. Immunol., 1997, 110(3), 485.
8. Nelson R.M. i wsp.: Heparin oligosaccharides bind L- i P-selection and inhibit acute inflammation. Blood, 1993, 82, 3253.
9. Xie X. i wsp.: Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo. Br. J. Pharmacol., 1997, 122, 906.
10. Yokokawa K. i wsp.: Heparin regulates endothelin production through endothelium-derived Nitric Oxiod in human endothelial cells. J. Clin. Invest., 1993, 92, 2080.
11. Jacoby D.B., Gleich G., Fryer A.D.: Human eosinophil Major Basic Protein is an endogenous allostenic antagonist at the inhibitory muscarinic M2 receptor. J. Clin. Invest., 1993, 91, 1314.
12. Ceyhan B., Celikel T.: Effect of inhaled heparin on metacholine-induced bronchial hyperreactivity. Eur. Respir. J., 1994, 7, S 18, 1453.
13. Pavord I. i wsp.: The effect of inhaled heparin on bronchial reactivity to sodium metabisulphate and metacholine in patients with asthma. Eur. Respir. J., 1996, 9, 217.
14. Cockoroft D.W., Murdock K.Y., Mink J.T.: Determination of histamine PC20. Chest 1983, 54, 505.
15. Dolowitz D.A., Dougherty T.F.: The use of heparin as an anti-inflammatory agent. Laryngoscope, 1960, 7 , 873.
16. Fine N.L., Shim C., Williams M.H. Jr.: Objective evaluation of heparin in the treatment of asthma. Am. Rev. Respir. Dis., 1968, 98, 886.
17. Antczak M., Kuna P.: Podawanie wziewne małych dawek heparyny w zapobieganiu wczesnemu skurczowi oskrzeli i wzrostowi niespecyficznej nadreaktywności oskrzeli po prowokacji alergenem. Postȩpy aerozoloterapii, 1995, 3, 3, 113.
18. Diamant Z. i wsp.: Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med., 1996, 153, 1790.
19. Polosa R. i wsp.: Time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled heparin in allergic asthma. J. Allergy. Clin. Immunol., 1997, 99(3), 338.
20. Kalpaklioglu A.F. i wsp.: Effect of pretreatment with heparin on pulmonary and cutaneous response. J. Asthma, 1997, 34(4), 337.